An exemplary clinician, educator and scientist, Stanley C. Jordan, M.D., has led major advances in nephrology and immunology that have significantly improved diagnostic techniques and treatment strategies for organ transplant patients.
Dr. Jordan is Professor of Medicine and Pediatrics at the David Geffen School of Medicine at UCLA. At Cedars-Sinai Medical Center in Los Angeles, he is Director of Pediatric Nephrology and Transplant Immunology and Medical Director of the Renal Transplant Program.
Raised in Sparta, North Carolina, he received both his undergraduate and medical degrees at the University of North Carolina. His internship and residency in pediatrics were at UCLA, where he also had a fellowship in pediatric nephrology. This was followed by a fellowship in experimental pathology at the Scripps Clinic & Research Foundation and a fellowship in dialysis and transplantation at Children’s Hospital Los Angeles. After a year as assistant clinical professor of pediatrics at the University of Southern California, he was appointed assistant professor of pediatrics at UCLA.
Dr. Jordan is one of the world’s foremost researchers in the area of immunological support for organ transplantation. He developed a process that uses intravenous immunoglobulin to reduce the risk of organ rejection in patients for whom other regimens have not been effective.
“Dr. Jordan’s research and leadership have had a profound and lasting impact on the field of transplantation,” says Randal Detwiler, M.D., Professor of Medicine and Medical Director of Kidney and Pancreas Transplantation at UNC. “He has advanced the understanding of immune-mediated disease processes, established important diagnostic techniques, developed unique and successful treatment strategies and protocols, and improved patient access to transplantation.”
By indentifying immunologic barriers to successful organ transplantation, Dr. Jordan has been able to design treatment protocols to circumvent those barriers. “His work has resulted in the successful kidney transplantation of many patients previously harboring little hope of coming off dialysis,” Dr. Detwiler says.
Dr. Jordan also created a technique for early-stage detection of post-transplant PTLD, a form of cancer that can be devastating in children. This technique allows for intervention to begin when it is most effective.
“Dr. Jordan is one of only a handful of superior researchers in diagnostic and treatment approaches for the care of patients receiving transplanted organs,” says Ronald Falk, M.D., Allen Brewster Distinguished Professor and Chief of the Division of Nephrology and Hypertension at UNC and Director of the UNC Kidney Center and the UNC Solid Organ Donor Transplant Program. “He is among the world’s nephrology elite, and my own patients have benefited from his contributions to the field.”
Dr. Jordan has served on the National Institute of Allergy and Infectious Disease Task Force to advise the U.S. Congress on the safety of intravenous immunoglobulin products. He also was appointed to the NIAID Task Force created to develop research priorities for kidney transplantation in the twenty-first century.
“His contributions have extended beyond the academic setting to the commercial sector and regulatory agencies, where his guidance has been invaluable in assuring optimum translation of academic advances to the care of patients,” says J. Charles Jennette, M.D., Brinkhous Distinguished Professor and Chair of Pathology and Laboratory Medicine and Professor of Medicine at UNC.
Dr. Jordan’s leadership positions at Cedars-Sinai include Director of the Transplant Immunology Laboratory and Medical Director of the Human Leukocyte Antigen (HLA) Laboratory.
He received the UCLA Alumni Association’s Medical Science Award in 2003 and was the 2006 recipient of the Gift of Life Award of the National Kidney Foundation. He has been honored for excellence in teaching at both UCLA and Cedars-Sinai.
Dr. Jordan has been a visiting professor at medical schools and hospitals throughout the United States and in Canada, Germany, Australia, Vietnam, Singapore, India, South Korea, Turkey and Taiwan.
“He unquestionably is a scholar, scientist and teacher of the highest distinction, whose original work has been internationally recognized and acclaimed,” says Dr. Jennette. “His accomplishments have had a tremendously beneficial impact on advancing knowledge of immunology, teaching physicians the science and art of medicine and improving the care of patients, especially those whose lives depend on successful organ transplantation.”
Dr. Detwiler adds: “Despite all of his success, Dr. Jordan remains approachable, humble, intellectually curious, collaborative and enthusiastic about the study of medicine.”
In recognition of his excellence as a physician, researcher and educator and his extraordinary contributions in the field of organ transplantation, we are proud to present the Distinguished Medical Alumnus Award to Stanley C. Jordan, M.D.